Diagnostic Value of TROP-2 and CK19 Expression in Papillary Thyroid Carcinoma in Both Surgical and Cytological Specimens

被引:13
|
作者
Abdou, Asmaa Gaber [1 ]
Shabaan, Mohammed [1 ]
Abdallha, Rania [1 ]
Nabil, Nehal [1 ]
机构
[1] Menoufia Univ, Fac Med, Dept Pathol, Gamal Abd Etnaser St 32511, Shebein Elkom, Egypt
来源
CLINICAL PATHOLOGY | 2019年 / 12卷
关键词
PTC; diagnosis; CK19; TROP-2; cytology; immunohistochemistry; CYTOKERATIN; 19; DIFFERENTIAL-DIAGNOSIS; FOLLICULAR VARIANT; GALECTIN-3; HBME-1; UTILITY; IMMUNOHISTOCHEMISTRY; LESIONS; BENIGN; MARKER;
D O I
10.1177/2632010X19863047
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Papillary thyroid carcinoma (PTC) represents the most common primary malignant thyroid tumor and its diagnosis is dependent on the presence of classic nuclear features that are sometimes seen in some non-neoplastic and benign lesions. Several immunohistochemical markers are used individually or in combination to help in differentiation of PTC from mimickers. The aim of the current study was to assess the diagnostic value of TROP-2 and cytokeratin 19 (CK19) expression in differentiating PTC from other mimickers both singly and in combination. The current study was carried out on 77 surgical specimens (56 PTC and 21 non-neoplastic cases) and 12 cytological specimens (4 THY2, 6 THY4, and 2 THY5). TROP-2 was negative in 81% of non-neoplastic surgical specimens and in 100% of THY2 cytological specimens while it was positive in 71.4% of PTC surgical specimens and 100% of THY4/THY5 cytological specimens. Sensitivity and specificity of TROP-2 positive expression for diagnosis of PTC in surgical specimens reached 71% and 81%. respectively, while it reached 100% for both in cytological specimens. Cytokeratin 19 showed positive expression in 85.7% of non-neoplastic surgical specimens and in 92.9% of PTC surgical specimens. Cytokeratin 19 showed negative expression in 75% of Thy2 cases while it was positive in all studied Thy4 and Thy5 cases. Sensitivity and specificity of CK19 total estimated score for diagnosis of PTC in surgical specimens were 78.6% and 66.7%. respectively, while it reached 100% and 75% in cytological specimens. Positive TROP-2 and CK19 expression in PTC were associated with lymph node metastasis. TROP-2 is a specific rather than sensitive marker while CK19 is a sensitive rather than specific marker in differentiating PTC from other mimickers in surgical specimens. The diagnostic validity of both markers was superior in diagnosis of classic PTC compared with follicular variant PTC. TROP-2 is superior to CK19 in diagnosis of PTC in cytological specimens. Both TROP-2 and CK19 could be used preoperatively in adjunct to hematoxylin and eosin for more confident diagnosis of thyroid cytology and along with radiology as predictors of lymph node metastasis.
引用
收藏
页数:16
相关论文
共 46 条
  • [11] Diagnostic and prognostic utility of TROP-2, SLP-2, and CXCL12 expression in papillary thyroid carcinoma
    Attia, Amany Selim
    Hussein, Samia
    Sameh, Hend
    Khalil, Amr
    Waley, Ahmad Barakat
    Matar, Ihab
    Sameh, Reham
    CANCER BIOMARKERS, 2024, 39 (03) : 211 - 221
  • [12] Expression of cytokeratin-19 (CK19) in the classical subtype of papillary thyroid carcinoma: the experience of one center in the Silesian region
    Kaliszewski, Krzysztof
    Diakowska, Dorota
    Strutynska-Karpinska, Marta
    Rzeszutko, Marta
    Grzegrzolka, Jedrzej
    Dziegiel, Piotr
    Wojtczak, Beata
    Sutkowski, Krzysztof
    FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2016, 54 (04) : 193 - 201
  • [13] RET/PTC and CK19 expression in papillary thyroid carcinoma and its clinicopathologic correlation
    Shin, E
    Chung, WY
    Yang, WI
    Park, CS
    Hong, SW
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2005, 20 (01) : 98 - 104
  • [14] Diagnostic utility of CK19 and CD56 in the differentiation of thyroid papillary carcinoma from its mimics
    Abouhashem, Nehal S.
    Talaat, Suzan M.
    PATHOLOGY RESEARCH AND PRACTICE, 2017, 213 (05) : 509 - 517
  • [15] Diagnostic value of HBME-1, CK19, Galectin 3, and CD56 in the subtypes of follicular variant of papillary thyroid carcinoma
    Cho, Haeyon
    Kim, Ji-Ye
    Oh, Young Lyun
    PATHOLOGY INTERNATIONAL, 2018, 68 (11) : 605 - 613
  • [16] CK19 IS A USEFUL MARKER IN DISTINGUISHING FOLLICULAR VARIANT OF PAPILLARY THYROID CARCINOMA FROM BENIGN THYROID LESIONS WITH FOLLICULAR GROWTH PATTERN
    Noroozinia, F.
    Gheibi, A.
    Ilkhanizadeh, B.
    Abbasi, A.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2016, 12 (04) : 387 - 391
  • [17] Significance of CK19, TPO, and HBME-1 expression for diagnosis of papillary thyroid carcinoma
    Liu, Zeming
    Yu, Pan
    Xiong, Yiquan
    Zeng, Wen
    Li, Xiaoyu
    Maiaiti, Yusufu
    Wang, Shuntao
    Song, Haiping
    Shi, Lan
    Liu, Chunping
    Cheng, Bo
    Zhang, Bo
    Ming, Jie
    Dong, Fang
    Ge, Hui
    Nie, Xiu
    Huang, Tao
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (03): : 4369 - 4374
  • [18] Evaluation of Diagnostic Utility of Immunohistochemistry Markers of TROP-2 and HBME-1 in the Diagnosis of Thyroid Carcinoma
    Zargari, Nooshin
    Mokhtari, Maral
    EUROPEAN THYROID JOURNAL, 2019, 8 (01) : 1 - 6
  • [19] Expression of CK-19 in Papillary Thyroid Carcinoma and Its Association with Prognostic Factors - A Cross-Sectional Study
    Revathy, V. J.
    Kumar, A. Sarath
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2021, 10 (11): : 813 - 818
  • [20] Diagnostic usefulness of HBME1, galectin-3, CK19, and CITED1 and evaluation of their expression in encapsulated lesions with questionable features of papillary thyroid carcinoma
    Scognamiglio, Theresa
    Hyjek, Elizabeth
    Kao, Jean
    Chen, Yao-Tseng
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2006, 126 (05) : 700 - 708